Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 970761, 6 pages
http://dx.doi.org/10.1155/2012/970761
Research Article

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma

Department of Neurosurgery, Second Hospital of Hebei Medical University, No. 215 Hepingxi Road, Hebei Province, Shijiazhuang City 050000, China

Received 30 September 2012; Accepted 22 October 2012

Academic Editor: Thomas Liehr

Copyright © 2012 Shengkui Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Marumoto and H. Saya, “Molecular biology of glioma,” Advances in Experimental Medicine and Biology, vol. 746, pp. 2–11, 2012. View at Google Scholar
  2. A. Rousseau, K. Mokhtari, and C. Duyckaerts, “The 2007 WHO classification of tumors of the central nervous system—What has changed?” Current Opinion in Neurology, vol. 21, no. 6, pp. 720–727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. A. Brandes, “State-of-the-art treatment of high-grade brain tumors,” Seminars in Oncology, vol. 30, no. 6, pp. 4–9, 2003. View at Google Scholar · View at Scopus
  4. H. Ohgaki and P. Kleihues, “Epidemiology and etiology of gliomas,” Acta Neuropathologica, vol. 109, no. 1, pp. 93–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Hutterer, P. Knyazev, A. Abate et al., “Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme,” Clinical Cancer Research, vol. 14, no. 1, pp. 130–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Tabatabai, M. Hegi, R. Stupp, and M. Weller, “Clinical implications of molecular neuropathology and biomarkers for malignant glioma,” Current Neurology and Neuroscience Reports, vol. 12, no. 3, pp. 302–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Visone and C. M. Croce, “MiRNAs and cancer,” American Journal of Pathology, vol. 174, no. 4, pp. 1131–1138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Katakowski, B. Buller, X. Wang, T. Rogers, and M. Chopp, “Functional microRNA is transferred between glioma cells,” Cancer Research, vol. 70, no. 21, pp. 8259–8263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Chan, S. Nama, F. Gopal et al., “Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas,” Cell Reports, vol. 2, no. 3, pp. 591–602, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik, “MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells,” Cancer Research, vol. 68, no. 19, pp. 8164–8172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Godlewski, M. O. Nowicki, A. Bronisz et al., “Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal,” Cancer Research, vol. 68, no. 22, pp. 9125–9130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Sasayama, M. Nishihara, T. Kondoh, K. Hosoda, and E. Kohmura, “MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC,” International Journal of Cancer, vol. 125, no. 6, pp. 1407–1413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Guan, M. Mizoguchi, K. Yoshimoto et al., “MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance,” Clinical Cancer Research, vol. 16, no. 16, pp. 4289–4297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. G. W. Verhaak, K. A. Hoadley, E. Purdom et al., “Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1,” Cancer Cell, vol. 17, no. 1, pp. 98–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Sasaki, G. Kohanbash, A. Hoji et al., “MiR-17-92 expression in differentiated T cells—implications for cancer immunotherapy,” Journal of Translational Medicine, vol. 8, article 17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Uziel, F. V. Karginov, S. Xie et al., “The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2812–2817, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Tagawa, K. Karube, S. Tsuzuki, K. Ohshima, and M. Seto, “Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development,” Cancer Science, vol. 98, no. 9, pp. 1482–1490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Tréguer, E.-M. Heinrich, K. Ohtani, A. Bonauer, and S. Dimmeler, “Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells,” Journal of Vascular Research, vol. 49, no. 5, pp. 447–460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Osada and T. Takahashi, “let-7 and miR-17-92: small-sized major players in lung cancer development,” Cancer Science, vol. 102, no. 1, pp. 9–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Fontana, M. E. Fiori, S. Albini et al., “Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM,” PLoS One, vol. 3, no. 5, Article ID e2236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Volinia, G. A. Calin, C. G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Malzkorn, M. Wolter, F. Liesenberg et al., “Identification and functional characterization of microRNAs involved in the malignant progression of gliomas,” Brain Pathology, vol. 20, no. 3, pp. 539–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, A. Dutta, and R. Abounader, “The role of microRNAs in glioma initiation and progression,” Frontiers in Bioscience, vol. 17, no. 2, pp. 700–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Tanzer and P. F. Stadler, “Molecular evolution of a microRNA cluster,” Journal of Molecular Biology, vol. 339, no. 2, pp. 327–335, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Ventura, A. G. Young, M. M. Winslow et al., “Targeted deletion reveals essential and overlapping functions of the miR-17~92 family of miRNA clusters,” Cell, vol. 132, no. 5, pp. 875–886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. K. M. Foshay and G. I. Gallicano, “miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation,” Developmental Biology, vol. 326, no. 2, pp. 431–443, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. W. Shan, D. Y. Lee, Z. Deng et al., “MicroRNA MiR-17 retards tissue growth and represses fibronectin expression,” Nature Cell Biology, vol. 11, no. 8, pp. 1031–1038, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Liu, Y. H. Gong, T. F. Chao et al., “Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas,” Chinese Medical Journal, vol. 122, no. 20, pp. 2405–2411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Ernst, B. Campos, J. Meier et al., “De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures,” Oncogene, vol. 29, no. 23, pp. 3411–3422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. A. Northcott, A. Fernandez-L, J. P. Hagan et al., “The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors,” Cancer Research, vol. 69, no. 8, pp. 3249–3255, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Luo, J. Zou, Z. Dong, Q. Zeng, D. Wu, and L. Liu, “Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma,” Biochemical Journal, vol. 442, no. 2, pp. 311–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. J. K. Molitoris, K. S. McColl, and C. W. Distelhorst, “Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17-92 contributes to the induction of bim and initiation of apoptosis,” Molecular Endocrinology, vol. 25, no. 3, pp. 409–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Zhou, J. M. Guo, Y. R. Lou et al., “Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker,” Journal of Molecular Medicine, vol. 88, no. 7, pp. 709–717, 2010. View at Publisher · View at Google Scholar · View at Scopus